Impact of age on outcome of CAR-T cell therapies for large B-cell lymphoma: the GLA/DRST experience

被引：26

作者：

Dreger, Peter ^{[1
]}

Holtick, Udo ^{[2
,3
]}

Subklewe, Marion ^{[4
]}

von Tresckow, Bastian ^{[5
]}

Ayuk, Francis ^{[6
]}

Wagner, Eva ^{[7
]}

Wulf, Gerald ^{[8
]}

Marks, Reinhardt ^{[9
]}

Penack, Olaf ^{[10
]}

Schnetzke, Ulf ^{[11
]}

Koenecke, Christian ^{[12
]}

von Bonin, Malte ^{[13
]}

Stelljes, Matthias ^{[14
]}

Glass, Bertram ^{[15
]}

Baldus, Claudia D. ^{[16
]}

Vucinic, Vladan ^{[17
]}

Mougiakakos, Dimitrios ^{[18
,19
]}

Topp, Max ^{[20
]}

Schroers, Roland ^{[21
]}

Wolff, Daniel ^{[22
]}

Thomas, Simone ^{[22
,23
]}

Kroeger, Nicolaus ^{[6
]}

Bethge, Wolfgang A. ^{[24
]}

机构：

[1] Univ Hosp Heidelberg, Dept Hematol & Oncol, Heidelberg, Germany

[2] Univ Cologne, Med Fac, Dept Internal Med 1, Cologne, Germany

[3] Univ Cologne, Univ Hosp Cologne, Cologne, Germany

[4] Ludwig Maximilians Univ Munchen, Univ Hosp Munich, Dept Hematol & Oncol, Munich, Germany

[5] Univ Duisburg Essen, Univ Hosp Essen, West German Canc Ctr, Dept Hematol & Stem Cell Transplantat, Essen, Germany

[6] Univ Hosp Hamburg, Dept Stem Cell Transplantat, Hamburg, Germany

[7] Univ Hosp Mainz, Dept Hematol & Oncol, Mainz, Germany

[8] Univ Med Goettingen, Clin Hematol & Med Oncol, Gottingen, Germany

[9] Univ Hosp Freiburg, Dept Hematol & Oncol, Freiburg, Germany

[10] Univ Hosp Charite, Dept Hematol & Oncol, Berlin, Germany

[11] Univ Hosp Jena, Dept Hematol & Oncol, Jena, Germany

[12] Univ Hosp Hannover, Dept Hematol & Oncol, Hannover, Germany

[13] Univ Hosp Dresden, Dept Hematol & Oncol, Dresden, Germany

[14] Univ Hosp Muenster, Dept Hematol & Oncol, Muenste, Germany

[15] Klinikum Berlin, Dept Hematol & Oncol, Berlin, Germany

[16] Univ Hosp Kiel, Dept Hematol & Oncol, Kiel, Germany

[17] Univ Hosp Leipzig, Leipzig, Germany

[18] Univ Hosp Erlangen, Dept Hematol & Oncol, Erlangen, Germany

[19] Univ Hosp Magdeburg, Dept Hematol, Magdeburg, Germany

[20] Univ Hosp Wurzburg, Dept Hematol & Oncol, Wurzburg, Germany

[21] Univ Hosp Bochum, Dept Hematol & Oncol, Bochum, Germany

[22] Univ Hosp Regensburg, Dept Internal Med 3, Hematol & Oncol, Regensburg, Germany

[23] Leibniz Inst Immunotherapy, Regensburg, Germany

[24] Univ Hosp Tuebingen, Dept Hematol & Oncol, Tubingen, Germany

来源：

BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 02期

关键词：

D O I：

10.1038/s41409-022-01867-4

中图分类号：

Q6 [生物物理学];

学科分类号：

071011 ;

摘要：

引用

页码：229 / 232

页数：4

共 50 条

[31] CAR-T cell lessons and news: Focus on large B-cell lymphomas
Dutari, Pilar
Brisou, Gabriel
HEMATOLOGIE, 2024, 30 : 14 - 28
[32] Cellular Therapy Updates in B-Cell Lymphoma: The State of the CAR-T
Crees, Zachary D.
Ghobadi, Armin
CANCERS, 2021, 13 (20)
[33] Evaluating Outcomes for Autologous Hematopoietic Cell Transplantation for Diffuse Large B-Cell Lymphoma in the CAR-T Era
Santapuram, Pranav R.
Rupji, Manali
Graiser, Michael
Waller, Edmund K.
Blum, Kristie A.
Allen, Pamela B.
Koff, Jean L.
Heffner, Leonard
Lechowicz, Mary Jo
Lonial, Sagar
Kaufman, Jonathan L.
Hofmeister, Craig C.
Dhodapkar, Madhav V.
Nooka, Ajay
Blum, William
Klisovic, Rebecca B.
Joseph, Nisha
Gupta, Vikas A.
Langston, Amelia
Cohen, Jonathon B.
BLOOD, 2020, 136
[34] NICE approves routine NHS use of CAR-T for diffuse large B-cell lymphoma
Wilkinson, Emma
LANCET ONCOLOGY, 2023, 24 (03): : 208 - 208
[35] Severe dysautonomia as a manifestation of neurotoxicity after CAR-T cell therapy for diffuse large B-cell lymphoma
El Chaer, Firas
Siegel, Ariel
Holtzman, Noa G.
Bukhari, Ali
Lutfi, Forat
Shah, Nirav G.
Yared, Jean A.
Rapoport, Aaron P.
McCurdy, Michael T.
Dahiya, Saurabh
AMERICAN JOURNAL OF HEMATOLOGY, 2020, 95 (06) : E146 - E148
[36] Prognostic value of early imaging following CAR-T cell therapy in diffuse large B-cell lymphoma
Bajwa, Amneet
Huang, Ying
Li, Rui
Denlinger, Nathan
Brammer, Jonathan
Penza, Sam
Saad, Ayman
Jaglowski, Samantha
Kittai, Adam S.
LEUKEMIA & LYMPHOMA, 2022, 63 (06) : 1492 - 1495
[37] Assessing and Management of Neurotoxicity After CAR-T Therapy in Diffuse Large B-Cell Lymphoma
Castaneda-Puglianini, Omar
Chavez, Julio C.
JOURNAL OF BLOOD MEDICINE, 2021, 12 : 775 - 783
[38] Geographical CAR-T Unmet Needs for Patients with Large B-Cell Lymphoma in the Province of Quebec
Murphy, Maria
Fromentin, Mathilde
Campeau, Julie
Sebag, Michael
Couture, Felix
Larouche, Jean-Francois
Lemieux, Christopher
Lachance, Silvy
Cohen, Sandra
Mollica, Luigina
Veilleux, Olivier
Fleury, Isabelle
BLOOD, 2022, 140 : 13228 - 13229
[39] The Impact of Bridging Therapy Prior to CAR-T Cell Therapy on Clinical Outcomes of Patients with Relapsed Refractory Large B-Cell Lymphoma
Lutfi, Forat
Kansagra, Ankit
Ali, Moaath Mustafa
Bukhari, Ali
Siglin, Jonathan
Yan, Jingsheng
Samanta, Santanu
Holtzman, Noa G.
Gottlieb, David
Kim, Dong Won
Lee, Seung-Tae
Kocoglu, Mehmet Hakan
Yared, Jean A.
Hardy, Nancy M.
Molitoris, Jason
Mohindra, Pranshu
Rapoport, Aaron P.
Dahiya, Saurabh
BLOOD, 2020, 136
[40] How to Sequence Therapies in Diffuse Large B-Cell Lymphoma Post-CAR-T Cell Failure
Logue, Jennifer M.
Chavez, Julio C.
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (12)

← 1 2 3 4 5 →